Lv5
806 积分 2025-01-21 加入
Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study
7天前
已完结
The changing epidemiology of patients with HCC receiving a first-line systemic therapy: insights from ARPES and ARTE databases (2008-2024)
7天前
已关闭
Risk factors for diagnostic delay in Chinese patients with hereditary angioedema
23天前
已完结
Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care
24天前
已完结
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
27天前
已完结
Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey
28天前
已完结
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase I Trial
29天前
已完结
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?
1个月前
已完结
Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain
1个月前
已完结
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
1个月前
已完结
皖公网安备34019202002308
